KR101971311B1 - 뉴라민산 유도체의 제조 방법 - Google Patents
뉴라민산 유도체의 제조 방법 Download PDFInfo
- Publication number
- KR101971311B1 KR101971311B1 KR1020147016077A KR20147016077A KR101971311B1 KR 101971311 B1 KR101971311 B1 KR 101971311B1 KR 1020147016077 A KR1020147016077 A KR 1020147016077A KR 20147016077 A KR20147016077 A KR 20147016077A KR 101971311 B1 KR101971311 B1 KR 101971311B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- compound represented
- acid
- prepare
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JPJP-P-2011-275819 | 2011-12-16 | ||
| JP2011275819 | 2011-12-16 | ||
| PCT/JP2012/082294 WO2013089168A1 (ja) | 2011-12-16 | 2012-12-13 | ノイラミン酸誘導体の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20140102216A KR20140102216A (ko) | 2014-08-21 |
| KR101971311B1 true KR101971311B1 (ko) | 2019-04-22 |
Family
ID=48612610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147016077A Active KR101971311B1 (ko) | 2011-12-16 | 2012-12-13 | 뉴라민산 유도체의 제조 방법 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20140356625A1 (https=) |
| EP (3) | EP2792676A4 (https=) |
| JP (1) | JP6038808B2 (https=) |
| KR (1) | KR101971311B1 (https=) |
| CN (3) | CN103974945B (https=) |
| BR (1) | BR112014014635A2 (https=) |
| CA (1) | CA2859296C (https=) |
| ES (1) | ES2640001T3 (https=) |
| HK (3) | HK1199034A1 (https=) |
| IL (2) | IL233124A0 (https=) |
| IN (1) | IN2014MN00971A (https=) |
| WO (1) | WO2013089168A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015032357A1 (zh) * | 2013-09-09 | 2015-03-12 | 中国科学院上海有机化学研究所 | 扎那米韦和拉那米韦的中间体及其合成方法 |
| CN113801138B (zh) * | 2020-06-12 | 2024-11-29 | 博瑞生物医药（苏州）股份有限公司 | 一种一锅法制备辛酸拉尼米韦中间体的方法 |
| CN113801082B (zh) * | 2020-06-12 | 2024-09-17 | 博瑞生物医药（苏州）股份有限公司 | 一种辛酸拉尼米韦的制备方法 |
| KR102405310B1 (ko) * | 2020-07-08 | 2022-06-02 | 가톨릭대학교 산학협력단 | 유체의 압력을 이용한 인공 요도괄약근 |
| CN114907301B (zh) * | 2021-02-10 | 2024-05-28 | 上海医药工业研究院 | 一种拉尼米韦辛酸酯中间体及其制备方法 |
| CN117814306A (zh) * | 2023-07-17 | 2024-04-05 | 铭畅生物医药南通有限公司 | 一种提高唾液酸酯稳定性的方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5141897B2 (https=) | 1972-11-30 | 1976-11-12 | ||
| JP2745059B2 (ja) * | 1989-03-08 | 1998-04-28 | メクト株式会社 | Ｎ―アセチルノイラミン酸ナトリウム・三水和物 |
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
| JPH0994768A (ja) * | 1995-09-29 | 1997-04-08 | Nippon Electric Ind Co Ltd | 車用電動工具 |
| US6340702B1 (en) | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6451766B1 (en) * | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| JP3209946B2 (ja) | 1996-07-22 | 2001-09-17 | 三共株式会社 | ノイラミン酸誘導体 |
| DE69709795T2 (de) * | 1996-07-22 | 2002-09-26 | Sankyo Co., Ltd. | Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung |
| US7330875B1 (en) | 1999-06-15 | 2008-02-12 | Microsoft Corporation | System and method for recording a presentation for on-demand viewing over a computer network |
| AU2001252578A1 (en) | 2000-04-25 | 2001-11-07 | Sankyo Company Limited | Preventives for influenza |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| JP3920041B2 (ja) | 2000-04-25 | 2007-05-30 | 三共株式会社 | ノイラミン酸化合物の水和物及び結晶 |
| JP4205314B2 (ja) | 2000-04-25 | 2009-01-07 | 第一三共株式会社 | インフルエンザ予防剤 |
| TWI389895B (zh) * | 2006-08-21 | 2013-03-21 | Infinity Discovery Inc | 抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法 |
| PL2123271T3 (pl) * | 2007-03-07 | 2012-03-30 | Daiichi Sankyo Co Ltd | Lek do leczenia grypy |
| TWI546306B (zh) * | 2007-04-11 | 2016-08-21 | 第一三共股份有限公司 | 神經胺酸衍生物之製造方法 |
| TWI491416B (zh) * | 2008-12-24 | 2015-07-11 | Daiichi Sankyo Co Ltd | 吸入用乾燥粉末醫藥組成物 |
| CN102050771A (zh) * | 2009-11-05 | 2011-05-11 | 沈阳万爱普利德医药科技有限公司 | 一个一种前列腺素衍生物的制造方法 |
-
2012
- 2012-12-13 HK HK14112666.2A patent/HK1199034A1/en unknown
- 2012-12-13 JP JP2013549304A patent/JP6038808B2/ja active Active
- 2012-12-13 IN IN971MUN2014 patent/IN2014MN00971A/en unknown
- 2012-12-13 EP EP12858308.5A patent/EP2792676A4/en not_active Withdrawn
- 2012-12-13 US US14/365,951 patent/US20140356625A1/en not_active Abandoned
- 2012-12-13 EP EP15174321.8A patent/EP2960236B1/en active Active
- 2012-12-13 CN CN201280062083.6A patent/CN103974945B/zh active Active
- 2012-12-13 ES ES15174321.8T patent/ES2640001T3/es active Active
- 2012-12-13 CN CN201510314576.XA patent/CN104926802B/zh active Active
- 2012-12-13 CA CA2859296A patent/CA2859296C/en not_active Expired - Fee Related
- 2012-12-13 CN CN201510314653.1A patent/CN105037309A/zh active Pending
- 2012-12-13 BR BR112014014635A patent/BR112014014635A2/pt not_active IP Right Cessation
- 2012-12-13 WO PCT/JP2012/082294 patent/WO2013089168A1/ja not_active Ceased
- 2012-12-13 KR KR1020147016077A patent/KR101971311B1/ko active Active
- 2012-12-13 EP EP15174323.4A patent/EP2960237A1/en not_active Withdrawn
-
2014
- 2014-06-15 IL IL233124A patent/IL233124A0/en unknown
- 2014-12-17 HK HK16106875.9A patent/HK1218912A1/en unknown
- 2014-12-17 HK HK16106872.2A patent/HK1218911A1/en unknown
-
2015
- 2015-01-18 IL IL236766A patent/IL236766A0/en unknown
-
2017
- 2017-01-09 US US15/401,665 patent/US20170114035A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2859296A1 (en) | 2013-06-20 |
| CN104926802B (zh) | 2018-02-13 |
| EP2960237A1 (en) | 2015-12-30 |
| US20140356625A1 (en) | 2014-12-04 |
| EP2792676A4 (en) | 2015-10-07 |
| CN103974945B (zh) | 2016-03-09 |
| HK1218911A1 (en) | 2017-03-17 |
| BR112014014635A2 (pt) | 2017-06-13 |
| HK1218912A1 (en) | 2017-03-17 |
| CA2859296C (en) | 2016-10-11 |
| IL233124A0 (en) | 2014-08-03 |
| EP2792676A1 (en) | 2014-10-22 |
| WO2013089168A1 (ja) | 2013-06-20 |
| CN104926802A (zh) | 2015-09-23 |
| IN2014MN00971A (https=) | 2015-05-22 |
| JP6038808B2 (ja) | 2016-12-07 |
| JPWO2013089168A1 (ja) | 2015-04-27 |
| US20170114035A1 (en) | 2017-04-27 |
| EP2960236A1 (en) | 2015-12-30 |
| ES2640001T3 (es) | 2017-10-31 |
| KR20140102216A (ko) | 2014-08-21 |
| EP2960236B1 (en) | 2017-06-14 |
| HK1199034A1 (en) | 2015-06-19 |
| IL236766A0 (en) | 2015-03-31 |
| CN103974945A (zh) | 2014-08-06 |
| CN105037309A (zh) | 2015-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101971311B1 (ko) | 뉴라민산 유도체의 제조 방법 | |
| JP5807983B2 (ja) | ノイラミン酸誘導体の製造方法 | |
| HK1159085B (en) | Method for manufacturing neuraminic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| FPAY | Annual fee payment |
Payment date: 20220323 Year of fee payment: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 8 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 8 |